Sumit Kumar, Associate Vice President, and Aritra Nandy, Consultant at Avalon Consulting shared their views on “Volume Rebound to Value Creation for Indian Agrochemical Industry,” published as an Chemical Industry Digest.
They highlighted that while global agrochemical demand is recovering and India’s export volumes are rebounding, long-term value creation will depend on overcoming structural challenges such as dependence on imported inputs, rising competition from Chinese players, and stringent regulatory barriers in high-margin markets. The article emphasizes that access to regulated markets is increasingly determined by regulatory approvals and compliance capabilities rather than price alone.
Global Trade Overview
The global agrochemicals market is entering into a phase of steady recovery after two years of weak demand. The demand slump, which was caused by widespread inventory destocking, is showing signs of reversal as distributors and importers across key geographies have started building up their inventory levels. At the same time, normalisation of agricultural activity in Asia and Latin America, followed by persistent pest pressures and changing crop patterns, is further contributing to the rising demand.
The recovery is reflected in the rebound of India’s export volumes across key markets. Export volumes to the U.S rebounded strongly in 2024, increasing by 14% after witnessing a decline in 2023. Similarly, exports to Brazil showed a sharp recovery, growing by 17% in 2024 following two years of muted, low single-digit growth. At an overall level, India’s agrochemical export volumes also improved, registering 7% growth in 2024 after remaining largely flat over the previous two years. For FY26, export revenues are expected to expand further, with growth estimated at around 8-9% during the year.
India’s agrochemical industry: Scale and growth outlook
The Indian agrochemicals sector is sizable and growing. It is currently estimated at ~INR 90,000 Cr with mid-single-digit to low-double-digit CAGR forecast over the next 5–7 years. From a demand and revenue outlook, a near-term recovery led by exports is being projected. On the supply side, India remains dependent on imported technicals and intermediates (primarily from China), which compresses margins. Global input prices are volatile, and competitive intensity is high due to rebound of Chinese capacity utilization, a dynamic which is visible in the global landscape. Finally, trade policy and new FTAs (for example, the recently announced India – EU/U.S agreement) represent a material upside if paired with regulatory alignment and capacity investments. Tariff and non-tariff easing could materially expand addressable export markets but will also raise the bar on quality, environmental compliance, and traceability.
Headwinds for India’s agrochemical exporters
Regulatory approvals as the key gatekeepers to high‑margin markets
Access to the world’s most valuable agrochemical markets is not dictated by price and trade alone. Regulatory approvals and scientific registrations act as barriers restricting access. In Europe, active ingredients are approved at the central level, whereas finished formulations are authorised country by country. The scientific risk assessment is handled by the European Food Safety Authority, and industrial chemical compliance is overseen by the European Chemicals Agency under REACH. The registration and approval process demands significant time and capital, but once acquired, it can provide a sustained competitive advantage. Similarly, markets such as the United States and Brazil are controlled through multi-layered approval processes, requiring comprehensive safety and environmental reviews before commercial use of agrochemicals.
These systems control access to such regulated markets for agrochemical trade. The impact of tariffs is inconsequential if exporters do not have the necessary registrations in place. These regulatory dossiers function as commercial assets, creating entry barriers that shield compliant players while keeping unregistered, low-cost competition out. This is resulting in global agrochemical exports being increasingly determined by regulatory capability and the ability to navigate these tightly guarded approval regimes.
How Chinese players are gaining ground in regulated markets
Chinese agrochemical exporters have increasingly broken into tightly regulated markets not by competing on price alone, but by acquiring regulatory access and building compliant portfolios that meet the same approval standards as Western and Indian players. The most important shift came through Chinese ownership of established global registrants, notably the acquisition of Syngenta. It allowed the transfer of hundreds of product registrations across the European Union, the US, Brazil, and other regulated markets. Chinese firms have also increased investment in product registrations to secure approvals in regulated markets. This has allowed them to compete with Indian exporters in high-margin regulated geographies, intensifying competition not just on cost, but on speed of registration, portfolio breadth, and global distribution scale.
US–China trade frictions are redirecting Chinese agrochemical exports
Broad reciprocal tariffs imposed by the United States on imports from China, with rates as much as 34% across many industrial and chemical product categories, is making the US market less appealing for Chinese exporters. Introduced as part of the wider U.S.–China trade conflict, these measures raised China’s tariff burden well above that of most trading partners and directly weakened the competitiveness of Chinese chemical inputs and intermediates that feed into agrochemical production.
Export analysis shows that Chinese agrochemical shipments are being redirected towards emerging markets with low tariff barriers. The export volumes to Brazil have risen by around 35% in 2025 over the previous year, and shipments to Indonesia were up by nearly 30% over the same period.
The shifting focus on these emerging markets is increasing price competition and market crowding for Indian agrochemical exporters operating in the same geographies where regulatory and tariff barriers are lower. This diversion is leading to muted value realisation for Indian exporters against a growing export volume.
Strategic pathways for Indian agrochemical exporters
Treat registrations and dossiers as strategic assets
Indian agrochemical firms should use product registrations and regulatory dossiers as strategic assets rather than one-time compliance costs. In regulated markets such as the US, EU, and Brazil, securing approvals requires multi-year investments often running into several million dollars per active ingredient.
These product registrations are critical levers as they offer legally protected market access for 10–15 years, restricting new entrants. Indian exporters need to build and own their own dossiers to create defensible export platforms. This will help de-risk regulatory disruptions, and shift from price-led generic competition toward asset-backed, high-margin market participation.
Use patent cliffs to launch early‑mover generics
Patent expiries open commercially large windows for generics. Industry analysis shows multiple active ingredients (AIs) are reaching patent expiry in the coming years. This will create a significant generic opportunity pool for agrochemical firms. For example, Cyantraniliprole and Pinoxaden are notable 2026 expiries that create generic opportunities in the insecticides and herbicides space, respectively. Historic trends show that patent expiries have led to large price declines and rapid generic penetration. This demonstrates how timely generic launches plus registration programmes translate to market share gain. Indian manufacturers can target AIs where patents expire and run coordinated dossier + field trial programs to capture early generic volumes.
Pair FTA benefits with registrations to unlock full value
India’s recent wave of trade agreements is creating a structural advantage for its agrochemical exporters. The real competitive edge emerges when tariff reductions are paired with regulatory approvals. Lower duties can translate into commercial gains if products are already registered and origin compliant. It will allow Indian firms to combine legal market access with improved landed-cost economics. This will allow Indian exporters position themselves more favourably against Chinese competitors who often face higher tariffs or lack preferential trade treatment in developed markets.
Recent trade agreements are reshaping India’s agrochemical export landscape. The notable India-EU FTA provides a big push to the agrochemicals sector as it will improve price competitiveness for agrochemical products. Alongside, regulatory cooperation on SPS is helping reduce delays without lowering safety standards.
Indian exporters who have already invested in registrations and compliant supply chains will enjoy a meaningful advantage. Their products can now enter markets like Europe, Australia, and New Zealand at a lower cost, providing them with a cost advantage. Potential changes in U.S. trade terms could strengthen this further.
Use licensing and partnerships to fast‑track market entry
Indian companies can focus on licensing existing dossiers or build partnerships with smaller registrants to gain faster and cost-effective entry into regulated markets. This removes the need to depend on expensive acquisitions and, therefore, the capital risk involved. This method will allow for immediate market access, reduce capital risk, and rapidly expand approved product portfolios. This enables quicker scaling in regulated geographies where time-to-approval is a critical competitive factor.
Win on compliance quality and ESG leadership
Environmental performance, traceability, and sustainable manufacturing practices are being focused on by global buyers and regulators. Indian firms need to invest in cleaner processes, accredited laboratories, waste minimization, and responsible stewardship initiatives to gain an advantage in this evolving scenario.
In the European Union, low-carbon manufacturing footprints, solvent recovery systems, zero-liquid-discharge plants, and full life-cycle impact data are becoming a necessary part of active ingredient approvals. Similar emphasis has been demonstrated by buyers and regulators in the US, where environmental compliance and worker safety records are becoming core evaluation criteria for agrochemical suppliers. There is also increased focus on batch-level traceability and structured training programs for distributors on safe and responsible product use.
ESG scorecards have become gatekeepers as global distributors are assessing factors such as emissions intensity, water usage intensity, hazardous waste treatment, and third-party audits before approving supply contracts. Strong ESG positioning, therefore, not only eases regulatory renewals but also builds long-term commercial trust and competitive advantage.
Shift toward specialty chemistries and advanced formulations
As Chinese exporters redirect volumes into emerging, lower-tariff markets, competition in these geographies is intensifying. This effect is more pronounced for the commoditised agrochemical categories, where China’s scale advantage leads to aggressive price wars and weaker margins. This evolving competitive landscape makes market analysis and portfolio diversification critical for Indian exporters seeking sustained profitability.
Market analysis reveals sustained global growth in speciality chemical segments as producers move away from commoditised competition. For Indian exporters, a data-driven shift toward these differentiated product clusters presents a clear pathway to capture higher margins, competing on value creation rather than sheer manufacturing scale.
Conclusion
The global agrochemical demand is rebounding, and Indian exporters are well placed to benefit from the recovery. The new market dynamic will be characterized by increased competition and higher compliance standards. Success in this market will depend on building strong regulatory capabilities.
Companies will also need to actively track patent expiration and leverage free trade agreements where registrations are already in place, allowing for faster and strategic market entry. Diversifying into specialty chemistries and advanced formulations will also be critical to improving margins. These strategies, paired with strong ESG performance and strategic partnerships, can help companies build durable advantages as the market enters its next growth phase.






